Moderate to Severe Chronic Plaque Psoriasis

DBCOND0032024Epidermal and dermal conditionsImmune System Diseases

Moderate to Severe Chronic Plaque Psoriasis is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Moderate-to-severe Chronic Plaque Psoriasis
Classified under
Indicated drugs

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
20Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Moderate to Severe Chronic Plaque Psoriasis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In